Literature DB >> 30918841

Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria.

Fakhraddeen Yahya Muhammad1, Latifah Musa Pedro2, Hassan Hassan Suleiman3, Andrew E Uloko1, Ibrahim D Gezawa1, Enikuomehin Adenike4, Mansur Ramalan5, Garba Iliyasu1.   

Abstract

INTRODUCTION: Diabetic foot ulcer is a major complication of diabetes with a high economic cost of managing. Data from resource limited setting will bring to light how patients in these localities suffer financially in addition to poverty and lack of health insurance. This study estimated cost of illness among patients with diabetic foot ulcer in northwestern Nigeria.
METHODS: It was a hospital based cross-sectional study. Questionnaire was used to take the bio data and medical history. Direct medical, direct non-medical and indirect cost were estimated. RESULT: Majority of the patients were males with the mean age of 59.3 ± 15.1 yrs. About 60% of the patients earn less than $100 monthly. The total cost of illness of diabetic foot ulcer was estimated at $140,735.56 (median = $1381.55[IQR 1002.42-]). Direct cost of illness was $107,797.06 (median = $1023.27[IQR 773.93-1568]), while the indirect cost was $32,938.49 (median = $209.90[IQR 128.74-357.08]). Out of pocket payment accounted for 90% of the payment.
CONCLUSION: The cost of diabetic foot ulcer is very exorbitant and the patients affected are mostly poor, unemployed and the breadwinners of their families.

Entities:  

Keywords:  Cost of care; Diabetes mellitus; Foot ulcer; Nigeria

Year:  2018        PMID: 30918841      PMCID: PMC6405375          DOI: 10.1007/s40200-018-0344-8

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  25 in total

Review 1.  Literature review on the management of diabetic foot ulcer.

Authors:  Leila Yazdanpanah; Morteza Nasiri; Sara Adarvishi
Journal:  World J Diabetes       Date:  2015-02-15

2.  The influence of gender as a risk factor in diabetic foot ulceration.

Authors:  Thanh Dinh; Aristidis Veves
Journal:  Wounds       Date:  2008-05       Impact factor: 1.546

3.  Diabetic foot complications and their risk factors from a large retrospective cohort study.

Authors:  Khalid Al-Rubeaan; Mohammad Al Derwish; Samir Ouizi; Amira M Youssef; Shazia N Subhani; Heba M Ibrahim; Bader N Alamri
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

4.  Foot care economics--cost burden to diabetic patients with foot complications: a study from southern India.

Authors:  R Shobhana; P R Rao; A Lavanya; V Vijay; A Ramachandran
Journal:  J Assoc Physicians India       Date:  2001-05

Review 5.  The costs of diabetic foot: the economic case for the limb salvage team.

Authors:  Vickie R Driver; Matteo Fabbi; Lawrence A Lavery; Gary Gibbons
Journal:  J Vasc Surg       Date:  2010-09       Impact factor: 4.268

6.  An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria.

Authors:  A O Ogbera; O Fasanmade; A E Ohwovoriole; O Adediran
Journal:  Int J Low Extrem Wounds       Date:  2006-12       Impact factor: 2.057

7.  Costs and duration of care for lower extremity ulcers in patients with diabetes.

Authors:  S E Holzer; A Camerota; L Martens; T Cuerdon; J Crystal-Peters; M Zagari
Journal:  Clin Ther       Date:  1998 Jan-Feb       Impact factor: 3.393

8.  Costs of lower-extremity ulcers among patients with diabetes.

Authors:  Karen Stockl; Ann Vanderplas; Eskinder Tafesse; Eunice Chang
Journal:  Diabetes Care       Date:  2004-09       Impact factor: 19.112

9.  Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.

Authors:  Caitlin W Hicks; Shalini Selvarajah; Nestoras Mathioudakis; Bruce A Perler; Julie A Freischlag; James H Black; Christopher J Abularrage
Journal:  J Vasc Surg       Date:  2014-06-14       Impact factor: 4.268

10.  Economic burden of illness associated with diabetic foot ulcers in Canada.

Authors:  Robert B Hopkins; Natasha Burke; John Harlock; Jathishinie Jegathisawaran; Ron Goeree
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.